Zhuhai Sailong Pharmaceutical Co Ltd Market Cap ($9.53 Million)
Market Cap & Net Worth: Zhuhai Sailong Pharmaceutical Co Ltd (002898)
Zhuhai Sailong Pharmaceutical Co Ltd market cap. Zhuhai Sailong Pharmaceutical Co Ltd (SHE:002898) has a market capitalization of $9.53 Million (CN¥65.12 Million) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #27045 globally and #4745 in its home market, demonstrating a 8.82% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhuhai Sailong Pharmaceutical Co Ltd's stock price CN¥0.37 by its total outstanding shares 176000000 (176.00 Million). Also see 002898 cash generation efficiency for how efficiently the company converts equity into cash flow.
Zhuhai Sailong Pharmaceutical Co Ltd Market Cap History (2017–2026)
Zhuhai Sailong Pharmaceutical Co Ltd market cap history from 2017 to 2026. Data shows change from $459.62 Million to $9.53 Million (-31.58% CAGR). Check Zhuhai Sailong Pharmaceutical Co Ltd share price for real-time trading data and today's change.
Zhuhai Sailong Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhuhai Sailong Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Zhuhai Sailong Pharmaceutical Co Ltd net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.68x
Zhuhai Sailong Pharmaceutical Co Ltd's market cap is 0.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $459.62 Million | $364.22 Million | $64.51 Million | 1.26x | 7.13x |
| 2018 | $345.39 Million | $436.27 Million | $60.90 Million | 0.79x | 5.67x |
| 2019 | $323.49 Million | $293.47 Million | $27.48 Million | 1.10x | 11.77x |
| 2020 | $240.51 Million | $120.68 Million | -$67.22 Million | 1.99x | N/A |
| 2021 | $268.52 Million | $247.08 Million | -$23.34 Million | 1.09x | N/A |
| 2022 | $312.21 Million | $264.19 Million | -$37.31 Million | 1.18x | N/A |
| 2023 | $358.97 Million | $310.63 Million | $9.53 Million | 1.16x | 37.65x |
| 2024 | $247.76 Million | $263.57 Million | -$33.15 Million | 0.94x | N/A |
| 2025 | $350.77 Million | $518.76 Million | -$121.17 Million | 0.68x | N/A |
Competitor Companies of 002898 by Market Capitalization
Companies near Zhuhai Sailong Pharmaceutical Co Ltd in the global market cap rankings as of November 5, 2026. Also see balance sheet size of Zhuhai Sailong Pharmaceutical Co Ltd for a full breakdown of the balance sheet.
Key companies related to Zhuhai Sailong Pharmaceutical Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #181 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #373 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #415 globally with a market cap of $67.74 Billion USD ( AU$95.74 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #503 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #181 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $549.04 |
| #373 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $930.67 |
| #415 | CSL Ltd | AU:CSL | $67.74 Billion | AU$197.34 |
| #503 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $258.38 |
Market Capitalization of Zhuhai Sailong Pharmaceutical Co Ltd (2017–2026)
Market capitalization of Zhuhai Sailong Pharmaceutical Co Ltd from 2017 to today. Between 2017 and today, Zhuhai Sailong Pharmaceutical Co Ltd's market cap moved from $459.62 Million to $ 9.53 Million, with a yearly change of -31.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥9.53 Million | -97.28% |
| 2025 | CN¥350.77 Million | +41.58% |
| 2024 | CN¥247.76 Million | -30.98% |
| 2023 | CN¥358.97 Million | +14.98% |
| 2022 | CN¥312.21 Million | +16.27% |
| 2021 | CN¥268.52 Million | +11.64% |
| 2020 | CN¥240.51 Million | -25.65% |
| 2019 | CN¥323.49 Million | -6.34% |
| 2018 | CN¥345.39 Million | -24.85% |
| 2017 | CN¥459.62 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Zhuhai Sailong Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.53 Million USD |
| MoneyControl | $9.53 Million USD |
| MarketWatch | $9.53 Million USD |
| marketcap.company | $9.53 Million USD |
| Reuters | $9.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhuhai Sailong Pharmaceutical Co Ltd
Sailong Pharmaceutical Group Co.,Ltd. researches, develops, produces, markets, and services pharmaceutical intermediates, raw materials, and preparations in China. The company offers esomeprazole sodium, ornithine aspartate, thymus, argatroban, tigecycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, pan… Read more